Aquarius Surgical Technologies Inc. (TSE:ASTI)
:ASTI
Top Page
Aquarius Surgical Technologies
(ASTI)
Select Model
Select Model
Rating:49Neutral
Price Target:
C$0.02
▲(50.00% Upside)
Action:ReiteratedDate:04/14/26
The score is primarily constrained by weak financial performance (declining revenue, losses, negative equity, and negative operating/free cash flow). Technicals provide some offset with price trading above key moving averages, while valuation appears optically cheap on P/E but is tempered by the lack of dividend support and the company’s financial instability.
Positive Factors
Industry Structural Demand
Operating in the medical devices industry provides durable structural support: demand is typically driven by demographics, routine hospital procurement cycles and non-cyclical healthcare spending. This gives a long-term market where product commercialization can compound over years.
Negative Factors
Revenue Decline
Sustained revenue decline reduces scale and erodes the unit economics critical for device makers. Falling top-line pressures gross margin absorption, limits reinvestment in R&D and commercialization, and makes it harder to achieve sustainable, profitable growth over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Industry Structural Demand
Operating in the medical devices industry provides durable structural support: demand is typically driven by demographics, routine hospital procurement cycles and non-cyclical healthcare spending. This gives a long-term market where product commercialization can compound over years.
Read all positive factors
Aquarius Surgical Technologies (ASTI) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$275.99K
Dividend YieldN/A
Average Volume (3M)6.90K
Price to Earnings (P/E)0.2
Beta (1Y)0.97
Revenue Growth-57.16%
EPS Growth2.93%
CountryCA
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.02
Shares Outstanding27,599,173
10 Day Avg. Volume4,405
30 Day Avg. Volume6,901
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.10
Price to Sales (P/S)6.05
P/FCF Ratio-1.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aquarius Surgical Technologies Business Overview & Revenue Model
Company Description
Aquarius Surgical Technologies (ASTI) is a pioneering company in the medical device sector, specializing in advanced surgical solutions designed to enhance patient outcomes and streamline surgical procedures. The company focuses on developing inno...
How the Company Makes Money
null...
Aquarius Surgical Technologies Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
20
Very Negative
Cash Flow
30
Negative
| Breakdown | Jun 2025 | Jun 2023 | Mar 2022 | Jun 2020 | Mar 2019 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 91.20K | 205.25K | 327.66K | 958.74K | 393.38K |
| Gross Profit | 47.31K | 132.85K | 130.30K | 378.25K | 161.41K |
| EBITDA | -832.81K | -456.62K | -611.35K | -1.18M | -1.24M |
| Net Income | -1.17M | -757.66K | -859.20K | -1.61M | -1.59M |
Balance Sheet | |||||
| Total Assets | 1.95M | 574.44K | 894.98K | 1.66M | 1.72M |
| Cash, Cash Equivalents and Short-Term Investments | 7.56K | 107.38K | 158.19K | 105.19K | 125.44K |
| Total Debt | 6.47M | 4.04M | 3.24M | 2.02M | 2.02M |
| Total Liabilities | 7.72M | 5.18M | 4.11M | 2.35M | 2.18M |
| Stockholders Equity | -5.77M | -4.61M | -3.21M | -689.15K | -453.90K |
Cash Flow | |||||
| Free Cash Flow | -383.29K | -256.92K | -117.38K | -1.07M | -2.17M |
| Operating Cash Flow | -383.29K | -252.56K | -112.16K | -951.17K | -1.35M |
| Investing Cash Flow | -1.80M | -4.36K | -5.22K | -86.99K | -818.55K |
| Financing Cash Flow | 2.08M | 242.29K | 129.59K | 1.02M | 1.72M |
Aquarius Surgical Technologies Technical Analysis
Positive
0.01
Price Trends
0.01
Positive
0.01
Positive
0.01
Positive
Market Momentum
>-0.01
Positive
58.85
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ASTI, the sentiment is Positive. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bullish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 58.85 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:ASTI.
Aquarius Surgical Technologies Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | C$18.77M | -5.28 | 106.68% | ― | 28.59% | 23.46% | |
49 Neutral | C$275.99K | 0.24 | 4.41% | ― | -57.16% | 2.93% | |
46 Neutral | C$21.47M | -29.60 | -31.12% | ― | 9.71% | -118.02% | |
46 Neutral | C$297.97M | -5.47 | -85.73% | ― | 72.03% | -1.47% | |
44 Neutral | C$39.73M | -5.70 | -220.14% | ― | 209.29% | 35.38% |
* Healthcare Sector Average
TSE:ASTI
Aquarius Surgical Technologies
0.02
>-0.01
-25.00%
TSE:ASG
Aurora Spine
0.28
-0.03
-11.29%
TSE:IME
Imagin Medical
0.02
0.00
0.00%
TSE:PINK
Perimeter Medical Imaging AI
0.43
0.00
0.00%
TSE:PRN
Profound Medical
8.51
1.84
27.59%
TSE:VPT
VentriPoint Diagnostics
0.11
-0.03
-22.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.